{"id":"W4415942079","doi":"10.1016/j.annonc.2025.08.2701","title":"2080eTiP A phase I/IIa, open-label, dose-finding study of the safety, pharmacokinetics, and preliminary efficacy of iza-bren (BL-B01D1) combinations in patients with advanced solid tumors","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Jewish General Hospital; Centre Hospitalier de l’Université de Montréal","funders":"Bristol-Myers Squibb","keywords":"Lung cancer; Conjugate; Solid tumor; Phases of clinical research; Monoclonal antibody; Response Evaluation Criteria in Solid Tumors; Antibody; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001409861,0.001529643,0.001936307,0.0007534261,0.0004931808,0.001107672,0.001014089,0.001228645,0.003480271],"category_scores_gemma":[0.0008203283,0.0007064588,0.001144134,0.0006145144,0.001003374,0.0008809197,0.0002940289,0.004335016,0.001180403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001074423,"about_ca_system_score_gemma":0.001629023,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001618728,"about_ca_topic_score_gemma":0.003312572,"domain_scores_codex":[0.9996058,0.0001911336,0.0000129907,0.00006112891,0.0000396485,0.000089314],"domain_scores_gemma":[0.9994734,0.0001139192,0.00007849318,0.00005546601,0.00003148055,0.0002472977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6275006,0.07761142,0.006466414,0.0006493936,0.001317794,0.0007206231,0.0004025752,0.005529585,0.1306337,0.001000602,0.009973416,0.1381939],"study_design_scores_gemma":[0.3876709,0.5736921,0.01275847,0.00003881183,0.0005484896,0.0008033295,0.0001068275,0.003787973,0.01350587,0.0005097875,0.006509766,0.00006773011],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895778,0.00190798,0.001235476,0.0005606595,0.0001185991,0.001356182,0.001827842,0.0003370812,0.003078499],"genre_scores_gemma":[0.9843448,0.001664191,0.003059271,0.0007633455,0.0001505913,0.001179919,0.004516718,0.0001118764,0.004209358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003480271,"threshold_uncertainty_score":0.01164269,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1152148650888674,"score_gpt":0.5120847254551094,"score_spread":0.396869860366242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}